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TBackground: The purpose of this study was to evaluate the long-term and midterm
effects of thoracic sympathectomy on pulmonary function and to assess the influ-
ence of the sympathetic nervous system on bronchomotor tone.
Methods: Thirty-seven consecutive patients were diagnosed with primary hyperhi-
drosis requiring thoracic sympathectomy and were included in this study. Spirom-
etry and methacholine challenge testing were performed before and 3 months after
surgery. To assess the long-term effects of the intervention, another spirometric
study was performed 1 year later.
Results: Spirometry 3 months after surgery showed a significant decrease in the
forced vital capacity (5.2%), the forced expiratory volume in the first second
(6.1%), and the forced expiratory flow between 25% and 75% of vital capacity
(5.1%). Whereas methacholine challenge testing before surgery was positive in 3
subjects (2 of whom were asthmatic), it was positive in 6 patients after the
procedure; differences were not statistically significant. After 12 months, forced
vital capacity started recovering, and forced expiratory volume in the first second
and forced expiratory flow rate 25% to 75% showed a sustained and significant
reduction (2.8% and 11.2%, respectively); however, patients remained asymp-
tomatic.
Conclusions: We conclude that thoracic sympathectomy generates a mild, although
significant, impairment of the bronchomotor tone, with no clinical consequences.
These results suggest that the sympathetic nervous system is involved in pulmonary
bronchomotor tone.
Primary hyperhidrosis is characterized by excessive idiopathic eccrine sweat-ing. It stems from a dysfunction of the autonomic nervous system that ismediated by cholinergic sympathetic fibers.1 It most frequently affects the
upper limbs (palmar and axillary zones). The definitive treatment of hyperhidrosis
is the complete excision, or the ablation with electrocautery or laser, of the T2 and
T3 sympathetic ganglia in palmar forms, with the additional excision of the T4
ganglion in axillary forms. Video-assisted endoscopic thoracic sympathectomy (TS)
was first described by Kux2 in 1954, and its further development in the 1990s made
it suitable as the treatment of choice for primary hyperhidrosis, given the good
results and the minimal morbidity and mortality associated with the procedure.3
The sympathetic trunks are 2 ganglionic nervous cords comprising several
segments: cervical, thoracic, abdominal, and pelvic. The pulmonary sympathetic
innervation derives mainly from the thoracic sympathetic chain (T2 to T8), but there
are also fascicles from the cervical sympathetic chain (cervicothoracic branches),
the stellate ganglion, and the cardiac plexus and fibers from intercostal nerves4
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CSP(Figure 1). Therefore, the TS procedure leads to a partial
sympathetic pulmonary denervation.5
The parasympathetic nervous system (PNS) regulates
the bronchomotor tone through the vagus nerve and is
involved in other functions, such as glandular secretion.
However, the role of the PNS in bronchomotor tone is not
fully understood. It is generally accepted that bron-
chomotor tone in humans is not controlled by sympa-
thetic nervous system (SNS) innervation but by circulat-
ing mediators and membrane receptors.6 Some authors
consider that the SNS helps to modulate the bronchomo-
tor tone, which exhibits a cholinergic preponderance,
particularly in conditions with increased tone, such as
bronchial asthma.7 Moreover, sympathetic innervation is
less abundant and comprises smaller fascicles than para-
sympathetic innervation.4,7 However, some studies show
that sympathetic innervation reaches even the distal area,
because amyelinic sympathetic nervous fibers have been
detected within bronchiolar smooth muscle and alveolar
ducts.8 This has been confirmed by electron microscopy,
which provided evidence for the presence of adrenergic
Figure 1. Diagram of pulmonary innervation derived from the
cervicothoracic sympathetic chain.nerves in the lower respiratory tract.9
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we studied the effects of TS on pulmonary function and
determined whether a sympathetic/parasympathetic imbal-
ance could contribute to impairment of the bronchomotor
tone.
Patients and Methods
Patients
The sample included 37 consecutive patients with primary hyper-
hidrosis unresponsive to conservative treatment and for whom the
indication of surgical treatment by video-assisted thoracoscopic
sympathectomy was ultimately established. The study protocol
was approved by the ethics committee at our institution.
Pulmonary Function Tests
Forced spirometry was performed before and 3 months after sur-
gery in all patients. Thirty-two patients had a new spirometry test
1 year after the TS. The same spirometer was used throughout the
study (Master Screen; Jaeger, Wuerzburg, Germany), and the
American Thoracic Society guidelines for spirometry were fol-
lowed.10 Recorded parameters were forced vital capacity (FVC),
forced expiratory volume in the first second (FEV1), peak expira-
tory flow (PEF), and forced expiratory flow during the middle half
of FVC (FEF 25%-75%). A methacholine challenge test was also
performed before and 3 months after surgery, according to the
American Thoracic Society standards.11 This was methacholine
testing with a dosimeter inhalation protocol (Jaeger). The test
started with the administration of saline followed by increasing
concentrations of methacholine (0.195, 0.39, 1.56, 6.25, 12.5, and
25 mg/mL). Thirty and ninety seconds after the last inhalation,
flow-volume curves were obtained to calculate FEV1. The test was
considered positive when an equal or greater than 20% decrease in
postinhalation FEV1 was observed and the PC20 (provocative
methacholine concentration causing a 20% decrease in FEV1 from
baseline) was established.
Video-Assisted Thoracoscopic Sympathectomy
Video-assisted thoracoscopic sympathectomy was performed un-
der general anesthesia with selective bronchial intubation with a
double-lumen endotracheal tube. The patient was placed in supine
position with both arms in abduction. Two incisions of 5 and 11.5
mm were made 3 cm apart on the medial and anterior axillary
lines, respectively. The sympathetic chain was electrocoagulated
with a video-endoscope and an endodissector between T2 and T3
for palmar hyperhidrosis, T3 and T4 for axillary hyperhidrosis, and
T2 and T4 for palmar and axillary hyperhidrosis. A pleural drain
was inserted and removed after lung expansion in the operating
room. The patient was transferred to a recovery room, where a
chest radiograph was obtained to verify complete lung expansion.
Statistical Analyses
The pulmonary function data are expressed as mean and SD.
Comparisons between the methacholine challenge testing results
before and after TS were performed by a 2 test. A paired Student
t test was performed to compare the pulmonary function data of the
37 patients before and 3 months after surgery. Finally, the analysis
of variance test for repeated measures was applied to analyze the
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Ppulmonary function data obtained from the 32 patients 12 months
after surgery. The Bonferroni test was used as a post hoc test.
Results
The study population consisted of 28 female and 9 male
patients with a mean age of 22.5 years (range, 15-50 years).
Two patients had asthma but were asymptomatic and re-
quired no bronchodilators. None of the patients was taking
any medication with cardiopulmonary effects, and none of
them was a smoker. No other patients, besides the 2 with
asthma, had any respiratory disease.
After TS, all patients fully recovered from hyperhidrosis,
which confirmed the interruption of the sympathetic chain
and the resulting partial pulmonary denervation. There were
no respiratory complications except for a pneumothorax in
1 patient. Spirometric parameters before surgery were
within the normal range (Table 1).
The methacholine challenge testing result was positive in
3 patients, 2 of whom were known to have asthma. In the
third patient, the result was considered a false positive,
because he had recently had a flulike syndrome.
Three months after the surgery, significant reductions in
FVC (0.193  0.273 L; 5.2%), FEV1 (0.150  0.212 L;
6.1%), and FEF 25% to 75% (0.170 0.458 L/s;5.1%)
were observed (Table 1). The PEF did not show significant
differences. Regarding the respiratory system, the patients
remained totally asymptomatic. The methacholine chal-
lenge testing 3 months after surgery was positive in 6
patients (2 of whom were known to have asthma). The
estimated PC20 for the 4 patients was always higher than 2
mg (2.599, 2.343, 2.855, and 2.510 mg). The observed
differences were not statistically significant.
In 32 of the 37 patients who started the study, control
spirometry was performed 12 months after surgery. The
results showed a slight recovery in FVC (3.99  0.70 L;
1.5%), which seemed to be nonsignificant. Significant
reductions in FEV1 (3.43  0.64 L; 2.8%) and FEF 25%
TABLE 1. Changes in pulmonary function 3 months after
surgery
Variable
Before TS
(mean  SD)
3 mo after TS
(mean  SD) P value
FVC (L) 4.21 0.81 4.01 0.77 .05
FVC (%) 107 11.7 101.8 9.6 .05
FEV1 (L) 3.72 0.68 3.57 0.66 .05
FEV1 (%) 111.1 13.4 105 11.7 .05
FEF25-75 (L/s) 4.18 1.08 4.01 1.1 .05
FEF25-75 (%) 103.4 25.3 98.3 28.7 .05
PEF (L) 8.23 2.03 8.55 2.09 .11
TS, Thoracic sympathectomy; FVC, forced vital capacity; FEV1, forced
expiratory volume in the first second; FEF25-75, forced expiratory flow during
the middle half of FVC; PEF, peak expiratory flow.to 75% (3.59  1.15 L/s; 11.2%) were observed, com-
The Journal of Thoracicpared with the values obtained 3 months after TS. Once
again, the differences in PEF were not statistically signifi-
cant (Table 2). Patients remained asymptomatic 12 months
after TS.
Discussion
Studies describing impairment of pulmonary function after
TS are scarce. Such studies have evaluated short-term and
midterm pulmonary function changes (1, 3, and 6 months
after TS).5,12-14 This study aimed to confirm the few exist-
ing data on pulmonary function after TS and to assess the
potential effects of this procedure on bronchial reactivity.
We studied patients 1 year after surgery to provide new data
from which conclusions were drawn regarding the role of
SNS in respiratory physiology and to test whether TS is a
safe technique devoid of long-term risks.
The first 2 studies on pulmonary function after TS were
published by Molho and colleagues12,13 in the 1970s and
1980s. They performed and compared sympathectomy with
thoracotomy through either the supraclavicular or the
transaxillary approach and observed a reduction in pulmo-
nary volumes and flows at 3 weeks and 3 and 6 months after
surgery. The surgical technique may have partially contrib-
uted to this decrease, as demonstrated by Furrer and asso-
ciates,15 who found that pulmonary function became close
to normal 4 months after surgery. Therefore, the observed
reduction can be ascribed, at least in part, to thoracotomy,
which causes a restrictive pattern in pulmonary function
tests.15 However, the persistence of low volumes and flows
6 months after surgery also suggests an impairment of the
bronchomotor tone, as demonstrated in our study.
Tseng and Tseng14 and Noppen and Vincken5 conducted
studies in which TS was performed with video-assisted
endoscopy. The first study showed a reduction in FEV1
(6.1%), FVC (2.3%), and FEF 75% (8%) 1 month
after the procedure. Even for minimally invasive operations,
TABLE 2. Changes in pulmonary function 3 and 12 months
after surgery
Variable
Before TS
(mean  SD)
3 mo after TS
(mean  SD)
12 mo after TS
(mean  SD)
FVC (L) 4.12 0.75 3.96 0.73* 3.99 0.70
FVC (%) 105.4 11.61 101.4 10* 102.9 13
FEV1 (L) 3.65 0.67 3.52 0.67* 3.43 0.64*
FEV1 (%) 109.9 13.4 105.2 12.4* 102.4 16.7*
FEF25-75 (L/s) 4.17 1.13 4.02 1.22 3.59 1.15*
FEF25-75 (%) 102.3 28.2 99  28.4 87.8 30.1*
PEF (L) 8.07 2.06 8.49 2.14 7.68 1.59
TS, Thoracic sympathectomy; FVC, forced vital capacity; FEV1, forced
expiratory volume in the first second; FEF25-75, forced expiratory flow during
the middle half of FVC; PEF, peak expiratory flow. *P  .05 compared with
pre-TS values.the postsurgical period allowed was excessively short, and
and Cardiovascular Surgery ● Volume 129, Number 6 1381
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CSPthis left open the possibility that changes were directly
related to the surgical technique. In the second study, pul-
monary function tests performed 3 months after the proce-
dure revealed a significant reduction in FEV1 (2.8%),
FVC (1.9%), and FEF 75% (6.5%). These values per-
sisted 6 months later in the case of FEV1 (3%) and FEF
75% (8.6%), whereas FVC showed an initial recovery.
Our data on FEV1 and midexpiratory flows confirmed the
3-month postoperative findings from Noppen and Vincken.5
Moreover, we observed a sustained and significant decrease
in FEV1 and FEF 25% to 75% 12 months after the surgical
intervention. We consider that a postoperative period of 1
year is long enough to determine whether TS can generate
bronchomotor tone disturbances independently of the sur-
gical trauma itself. A reduction in FVC after 3 months could
be due to restrictive constraints imposed by the surgical
technique, because this parameter recovered by 12 months,
whereas the reductions in FEV1 and FEF 25% to 75%
remained.15 The finding that FVC returned to a preoperative
range, together with a persistent reduction in FEV1 and FEF
25% to 75%, indicates that partial sympathetic denervation
is responsible for the long-term increased bronchomotor
tone. Such changes, although significant, are small and
clinically irrelevant. None of the 32 patients had respiratory
symptoms. They all had adequate exercise tolerance and
good general conditions. Together, these results allow us to
conclude that TS is a safe exploratory procedure that is
devoid of long-term secondary respiratory effects.
With the aim of assessing SNS/PNS balance, we also
performed methacholine challenge testing in the patients
who underwent TS. Our starting hypothesis was that sym-
pathetic denervation would cause an increase in cholinergic
tone, so we could expect a significant number of positive
results 3 months after surgery. However, the differences
observed were not significant. This result is consistent with
the less abundant and smaller fascicles of sympathetic in-
nervation compared with parasympathetic innervation.4,7
Also, TS generates partial sympathetic denervation with
some remaining cervicothoracic branches, with the capacity
to innervate the bronchial tree.4 Alternatively, methacholine
could stimulate cholinergic receptors and induce a PNS-
mediated bronchial constriction. In this way, methacholine
challenge testing evaluates the role of PNS on the airways,
which is theoretically normal in patients subjected to TS.
Among our patients, there were 2 known to have asthma in
stable condition that did not require continuous medication.
In these patients, the methacholine testing was positive
before and after TS; during follow-up, they experienced
neither particular respiratory symptoms nor the need for
rescue bronchodilators, which would suggest a worsening
of their background condition. Among the patients studied,
3 with a prior negative methacholine challenge test had a
1382 The Journal of Thoracic and Cardiovascular Surgery ● Junpositive result after surgery. We have no clear explanation
for this observation; the patients were asymptomatic, and
their PC20 values were high—close to the maximal dose
establishing the test as positive11—suggesting that these
values could lay within the variability range attributable to
the test.16
The results from our research enabled us to conclude that
TS is a safe technique in the long term, because the reduc-
tion of volumes and flows is minimal and clinically irrele-
vant. We also demonstrated that SNS is involved in pulmo-
nary bronchomotor tone, at least in patients with primary
hyperhidrosis. The evidence for this is the sustained and
significant long-term decrease in FEV1 and FEF 25% to
75%. To our knowledge, this is the first report in the
literature assessing long-term effects of TS on pulmonary
function 1 year after surgery.
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